Presentation TCT 2021 TARGET Clinical Trials Roadmap & TARGET IV NA Trial Design Presenter: Martin Leon November 06, 2021
Presentation TCT 2021 TIDES-ACS: Three-Year Outcomes From a Randomized Trial of Titanium Nitride Oxide-Coated Versus Everolimus-eluting Stents in Patients With Acute Coronary Syndromes Presenter: Pasi Karjalainen November 06, 2021
Presentation TCT 2021 BIODEGRADE: Three-Year Outcomes From a Randomized Trial of Biolimus-eluting Versus Zotarolimus-eluting Stents in Patients With Coronary Artery Disease Presenter: IN-HO CHAE November 06, 2021
Presentation TCT 2021 BIO-RESORT: Five-Year Outcomes from a Randomized Trial of Three Drug-Eluting Stents in Patients With Coronary Artery Disease Presenter: Eline Ploumen November 06, 2021
Presentation TCT 2021 Clinical Trials Paving the Way for Data Presenter: Robert Lookstein November 06, 2021
Presentation TCT 2021 One-year Outcomes of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis Lesions Presenter: Bruno Scheller November 06, 2021
Presentation TCT 2021 BIO-RISE CHINA: A Randomized Trial of a Biolimus-Coated Balloon Versus POBA in Small Vessel Coronary Artery Disease Presenter: Yaling Han November 06, 2021
Presentation TCT 2021 A Randomized Trial of Sirolimus-coated Versus Paclitaxel-coated Balloons in De Novo Coronary Lesions Presenter: Wan Azman Wan Ahmad November 06, 2021
Presentation TCT 2021 GUIDE-HF: A Randomized Trial of Hemodynamic-Guided Management of Heart Failure – Outcomes According to Ejection Fraction Presenter: Michael Zile November 06, 2021
Presentation TCT 2021 OPT-PEACE: A Double-blind Randomized Trial of the Effect of Different Antiplatelet Regimens on Gastrointestinal Injury Presenter: Yaling Han November 06, 2021
Presentation TCT 2021 SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure Presenter: Roberto Galea November 06, 2021
Presentation TCT 2021 Latest Evidence in the SPYRAL-HTN Clinical Program Presenter: NULL November 05, 2021
Presentation TCT 2021 MASTER-DAPT: A Randomized Trial of Abbreviated Antiplatelet Therapy - Outcomes in High Bleeding Risk Patients With High Thrombotic and Ischemic Risk Presenter: Pieter Smits November 05, 2021
Presentation TCT 2021 PRAGUE-17: Three-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure Versus Direct Acting Oral Anticoagulation in Patients With Atrial Fibrillation Presenter: Pavel Osmancik November 05, 2021
Presentation TCT 2021 AMULET IDE: One-Year Device Closure From a Randomized Trial of Amulet Versus Watchman for Left Atrial Appendage Occlusion Presenter: Dhanunjaya Lakkireddy November 05, 2021
Presentation TCT 2021 CHOICE-CLOSURE: A Randomized Trial of Plug-Based Versus Suture-Based Large-Bore Vascular Closure Presenter: Mohamed Abdel-Wahab November 05, 2021
Presentation TCT 2021 PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk Presenter: David Cohen November 05, 2021
Presentation TCT 2021 SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk Presenter: Nicolas Van Mieghem November 05, 2021
Presentation TCT 2021 Perspectives on TEER Trials in Secondary MR (Control Groups, Enrollment Issues, and More) Presenter: Ori Ben-Yehuda November 05, 2021
Presentation TCT 2021 Perspectives on TEER Trials in Primary MR: From Prohibitive to Intermediate and Low Risk Presenter: Joanna Chikwe November 05, 2021